Insider Trading in Lantheus Holdings: Why Gerard’s Sale Isn’t a Red Flag for Investors
Ber Gerard’s May 14 sale of Lantheus shares shows no market shift—insider confidence stays high, and the firm’s strong diagnostics pipeline suggests a good entry point near $100 before a potential rebound toward its 52‑week high.
3 minutes to read


